Rapid and scalable preclinical evaluation of personalized antisense oligonucleotide therapeutics using organoids derived from rare disease patients https://www.medrxiv.org/content/10.1101/2023.03.28.23287871
Rapid and scalable preclinical evaluation of personalized antisense oligonucleotide therapeutics using organoids derived from rare disease patients https://www.medrxiv.org/content/10.1101/2023.03.28.23287871